New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA

Palladium and platinum complexes with the model nucleobase 1-methylcytosine (1-Mecyt) of the types [Pd(N-N)(C6F5)(1-Mecyt)]ClO4 [N-N = bis(3,5-dimethylpyrazol-1-yl)methane (bpzm), bis(pyrazol-1-yl)methane (bpzm), N,N,N',N'-tetramethylethylenediamine (tmeda), or 2,2'-bipyridine (bpy)] and [M(dmba)(L')(1-Mecyt)]ClO4 [dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl; L' = PPh(3) (M = Pd or Pt), DMSO (M = Pt)] have been obtained. Palladium and platinum complexes of the types cis-[M(C6F5)2(1-Mecyt)2] (M = Pd or Pt) and cis-[Pd(L')(C6F5)(1-Mecyt)2]ClO4 (L' = PPh(3) or t-BuNC) have also been prepared. The crystal structures of [Pd(bpzm)(C6F5)(1-Mecyt)]ClO4, [Pt(dmba)(DMSO)(1-Mecyt)]ClO4, cis-[Pd(C6F5)2(1-Mecyt)2], and cis-[Pd(t-BuNC)(C6F5)(1-Mecyt)2]ClO4 have been established by X-ray diffraction. There is extensive hydrogen bonding (N-H...O, C-H...F or C-H...O) in all the compounds. There are also intermolecular pi-pi interactions between pyrimidine rings of adjacent chains in [Pd(C6F5)2(1-Mecyt)2]. DNA adduct formation of the new complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the complexes on plasmid DNA pBR322 were also obtained. Values of IC(50) were also calculated for the new complexes against the tumor cell line HL-60. At a short incubation time (24 h) almost all new complexes were more active than cisplatin.     

Synthesis and Reactivity of (Pentafluorophenyl)platinate(II) Complexes with Bridging 1,8-Naphthyridine (napy) and X Ligands (X = C(6)F(5), OH, Cl, Br, I, SPh). Crystal Structure of [NBu(4)][Pt(2)(&mgr;-napy)(&mgr;-OH)(C(6)F(5))(4)].CHCl(3)

By reaction of [NBu(4)](2)[Pt(2)(&mgr;-C(6)F(5))(2)(C(6)F(5))(4)] with 1,8-naphthyridine (napy), [NBu(4)][Pt(C(6)F(5))(3)(napy)] (1) is obtained. This compound reacts with cis-[Pt(C(6)F(5))(2)(THF)(2)] to give the dinuclear derivative [NBu(4)][Pt(2)(&mgr;-napy)(&mgr;-C(6)F(5))(C(6)F(5))(4)] (2). The reaction of several HX species with 2 results in the substitution of the bridging C(6)F(5) by other ligands (X) such as OH (3), Cl (4), Br (5), I (6), and SPh (7), maintaining in all cases the naphthyridine bridging ligand. The structure of 3 was determined by single-crystal X-ray diffraction. The compound crystallizes in the monoclinic system, space group P2(1)/n, with a = 12.022(2) ?, b = 16.677(3) ?, c = 27.154(5) ?, beta = 98.58(3) degrees, V = 5383.2(16) ?(3), and Z = 4. The structure was refined to residuals of R = 0.0488 and R(w) = 0.0547. The complex consists of two square-planar platinum(II) fragments sharing a naphthyridine and OH bridging ligands, which are in cis positions. The short Pt-Pt distance [3.008(1) ?] seems to be a consequence of the bridging ligands.     

Synthesis and in solution and solid state structural study of intramolecular Pt...H interactions in pentafluorophenyl platinum(II) complexes containing the ligands triazene, formamidine, and 2-aminopyridine

The preparation of the [NBu4][Pt(C6F5)3L] complexes (L=triazene, formamidine, 2-aminopyridine,) have been carried out. These ligands contain a hydrogen atom, with more or less acidic character, in a position suitable for establishing an intramolecular hydrogen bonding interaction with the metal center. This interaction has been detected in solution for; its 1H NMR spectrum shows that the resonance assignable to this hydrogen has platinum satellites. For, this coupling is not observed, and the interaction, if it exists, has to be weaker because of the less acidic character of the hydrogen atom. The 2-aminopyridine ligand is more flexible than the triazene or formamidine, and also in this case, no evidence of the interaction in solution is obtained. Nevertheless, if another potential proton acceptor is present, such as ClO4- in [NBu4]2[Pt(C6F5)3(C5H6N2)](ClO4), a conventional N-H...O-Cl hydrogen bond is formed. The crystal structures of complexes have been determined by X-ray diffraction.     

Alkynyldiphenylphosphine d8 (Pt, Rh, Ir) complexes: contrasting behavior toward cis-[Pt(C6F5)2(THF)2

The synthesis and characterization of a series of mononuclear d(8) complexes with at least two P-coordinated alkynylphosphine ligands and their reactivity toward cis-[Pt(C(6)F(5))(2)(THF)(2)] are reported. The cationic [Pt(C(6)F(5))(PPh(2)C triple-bond CPh)(3)](CF(3)SO(3)), 1, [M(COD)(PPh(2)C triple-bond CPh)(2)](ClO(4)) (M = Rh, 2, and Ir, 3), and neutral [Pt(o-C(6)H(4)E(2))(PPh(2)C triple-bond CPh)(2)] (E = O, 6, and S, 7) complexes have been prepared, and the crystal structures of 1, 2, and 7.CH(3)COCH(3) have been determined by X-ray crystallography. The course of the reactions of the mononuclear complexes 1-3, 6, and 7 with cis-[Pt(C(6)F(5))(2)(THF)(2)] is strongly influenced by the metal and the ligands. Thus, treatment of 1 with 1 equiv of cis-[Pt(C(6)F(5))(2)(THF)(2)] gives the double inserted cationic product [Pt(C(6)F(5))(S)mu-(C(Ph)=C(PPh(2))C(PPh(2))=C(Ph)(C(6)F(5)))Pt(C(6)F(5))(PPh(2)C triple-bond CPh)](CF(3)SO(3)) (S = THF, H(2)O), 8 (S = H(2)O, X-ray), which evolves in solution to the mononuclear complex [(C(6)F(5))(PPh(2)C triple-bond CPh)Pt(C(10)H(4)-1-C(6)F(5)-4-Ph-2,3-kappaPP'(PPh(2))(2))](CF(3) SO(3)), 9 (X-ray), containing a 1-pentafluorophenyl-2,3-bis(diphenylphosphine)-4-phenylnaphthalene ligand, formed by annulation of a phenyl group and loss of the Pt(C(6)F(5)) unit. However, analogous reactions using 2 or 3 as precursors afford mixtures of complexes, from which we have characterized by X-ray crystallography the alkynylphosphine oxide compound [(C(6)F(5))(2)Pt(mu-kappaO:eta(2)-PPh(2)(O)C triple-bond CPh)](2), 10, in the reaction with the iridium complex (3). Complexes 6 and 7, which contain additional potential bridging donor atoms (O, S), react with cis-[Pt(C(6)F(5))(2)(THF)(2)] in the appropriate molar ratio (1:1 or 1:2) to give homo- bi- or trinuclear [Pt(PPh(2)C triple-bond CPh)(mu-kappaE-o-C(6)H(4)E(2))(mu-kappaP:eta(2)-PPh(2)C triple-bond CPh)Pt(C(6)F(5))(2)] (E = O, 11, and S, 12) and [(Pt(mu(3)-kappa(2)EE'-o-C(6)H(4)E(2))(mu-kappaP:eta(2)-PPh(2)C triple-bond CPh)(2))(Pt(C(6)F(5))(2))(2)] (E = O, 13, and S, 14) complexes. The molecular structure of 14 has been confirmed by X-ray diffraction, and the cyclic voltammetric behavior of precursor complexes 6 and 7 and polymetallic derivatives 11-14 has been examined.     

Synthesis and reactivity of bridging and terminal hydrosulfido palladium and platinum complexes. Crystal structures of [NBu4]2[(Pt(c6F5)2(mu-SH)]2], [Pt(C6F5)2(PPh3)[S(H)AgPPh3]], and [Pt(C6F5)2(PPh3)[S(AuPPh3)2]

The reactions of the hydroxo complexes [M(2)R(4)(mu-OH)(2)](2)(-) (M = Pd, R = C(6)F(5), C(6)Cl(5); M = Pt, R = C(6)F(5)), [[PdR(PPh(3))(mu-OH)](2)] (R = C(6)F(5), C(6)Cl(5)), and [[Pt(C(6)F(5))(2)](2)(mu-OH)(mu-pz)](2-) (pz = pyrazolate) with H(2)S yield the corresponding hydrosulfido complexes [M(2)(C(6)F(5))(4)(mu-SH)(2)](2-), [[PdR(PPh(3))(mu-SH)](2)], and [[Pt(C(6)F(5))(2)](2)(mu-SH)(mu-pz)](2-), respectively. The monomeric hydrosulfido complexes [M(C(6)F(5))(2)(SH)(PPh(3))](-) (M = Pd, Pt) have been prepared by reactions of the corresponding binuclear hydrosulfido complexes [M(2)(C(6)F(5))(4)(mu-SH)(2)](2-) with PPh(3) in the molar ratio 1:2, and they can be used as metalloligands toward Ag(PPh(3))(+) to form the heterodinuclear complex [(C(6)F(5))(2)(PPh(3))[S(H)AgPPh(3)]], and toward Au(PPh(3))(+) yielding the heterotrinuclear complexes [M(C(6)F(5))(2)(PPh(3))[S(AuPPh(3))(2)]]. The crystal structures of [NBu(4)](2)[[Pt(C(6)F(5))(2)(mu-SH)](2)], [Pt(C(6)F(5))(2)(PPh(3))[S(H)AgPPh(3)]], and [Pt(C(6)F(5))(2)(PPh(3))[S(AuPPh(3))(2)]] have been established by X-ray diffraction and show no short metal-metal interactions between the metallic centers.     

Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds

Palladium and platinum complexes with HmtpO (where HmtpO=4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, an analogue of the natural occurring nucleobase hypoxanthine) of the types [M(dmba)(PPh3)(HmtpO)]ClO4[dmba=N,C-chelating 2-(dimethylaminomethyl)phenyl; M=Pd or Pt], [Pd(N-N)(C6F5)(HmtpO)]ClO4[N-N=2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), or N, N, N', N'-tetramethylethylenediamine (tmeda)] and cis-[M(C6F5)2(HmtpO)2] (M=Pd or Pt) (head-to-head atropisomer in the solid state) have been obtained. Pd(II) and Pt(II) complexes with the anion of HmtpO of the types [Pd(tmeda)(C6F5)(mtpO)], [Pd(dmba)(micro-mtpO)] 2, and [NBu4]2[M(C6F5)2(micro-mtpO)]2(M=Pd or Pt) have been prepared starting from the corresponding hydroxometal complexes. Complexes containing simultaneously both the neutral HmtpO ligand and the anionic mtpO of the type [NBu4][M(C6F5)2(HmtpO)(mtpO)] (M=Pd or Pt) have been also obtained. In these mtpO-HmtpO metal complexes, for the first time, prototropic exchange is observed between the two heterocyclic ligands. The crystal structures of [Pd(dmba)(PPh 3)(HmtpO)]+, cis-[Pt(C6F5)2(HmtpO)2].acetone, [Pd(C6F5)(tmeda)(mtpO)].2H2O, [Pd(dmba)(micro-mtpO)]2, [NBu4]2[Pd(C6F5)2(micro-mtpO)]2.CH2Cl2.toluene, [NBu4]2[Pt(C6F5)2(micro-mtpO)](2).0.5(toluene), and [NBu4][Pt(C6F5)2(mtpO)(HmtpO)] have been established by X-ray diffraction. Values of IC50 were calculated for the new platinum complexes cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR), lung (NCI-H460), and breast cancers (T47D). At 48 h incubation time, both complexes were about 8-fold more active than cisplatin in T47D and show very low resistance factors against an A2780 cell line, which has acquired resistance to cisplatin. The DNA adduct formation of cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by these platinum complexes on plasmid DNA pB R322 were also obtained.     

Synthesis of binuclear platinum complexes containing the ligands 8-naphthyridine, 2-aminopyridine, and 7-azaindolate. An experimental study of the steric hindrance of the bulky pentafluorophenyl ligands in the synthesis of binuclear complexes

The bidentate N-donor ligands 2-aminopyridine (2-ampy), 7-azaindolate (aza) and 1,8-naphthyridine (napy) have been used to study the steric effect of pentafluorophenyl groups in the synthesis of binuclear platinum(II) complexes. The 2-ampy and aza ligands bridge two "Pt(C 6F 5) 2" fragments with Pt...Pt distances of 4.1 and 3.4 A, respectively (complexes 1 and 3). Under the same reaction conditions the napy ligand shows chelating behavior and makes the mononuclear complex ( A) highly reactive because of its strained coordination. One of the Pt-N bonds of the chelating complex is broken on reaction with HX {X = Cl ( 4), Br ( 5)} because of protonation while the anion X (-) occupies a created vacant site. The resulting mononuclear complex eliminates C 6F 5H when refluxed, and a binuclear complex ( 6) with two napy ligands bridging two "Pt(C 6F 5)Cl" fragments is obtained. The reaction of A with HPPh 2 affords a mononuclear complex ( 7) analogous to complexes 5 and 6, but reflux gives a binuclear complex ( 8) with the two napy ligands terminally bound and the PPh 2 groups bridging the "Pt(C 6F 5)napy" moieties. The reaction of A with HCCPh gives a binuclear complex; moreover, the final product does not depend on the ratio of complex A to HCCPh. Complexes 1, 4, 6, 9 have been structurally characterized by X-ray diffraction.     

One- or two-dimensional 2,3-naphtho crown ether complexes [Na(N15C5)]2[M(SCN)4] and [K(N18C6)]2[M(SCN)4] (M = Pd, Pt) constructed by pi-pi stacking interactions

Four novel 2,3-naphtho-15-crown-5 (N15C5) and 2,3-naphtho-18-crown-6 (N18C6) complexes [Na(N15C5)]2[Pd(SCN)4] (1), [Na(N15C5)]2[Pt(SCN)4] (2), [K(N18C6)]2[Pd(SCN)4] (3) and [K(N18C6)]2[Pt(SCN)4] (4) were synthesized and characterized by elemental analysis, FT-IR spectra and single-crystal X-ray diffraction. The structure analyses reveal that both 1 and 2 are assembled into zigzag chains by the strong intermolecular pi-pi stacking interactions between adjacent 2,3-naphthylene groups of N15C5. The molecules of complexes 3 and 4 are linked into 1D chains by the bridging K-O(ether) interactions between the adjacent [K(N18C6)]+ units and the resulting chains are constructed into a novel 2D network by inter-chain pi-pi stacking interactions between the neighboring 2,3-naphthylene moieties of N18C6. According to the supramolecular self-assemblies of complexes 1-4, two types of stacking model of naphthylene groups are given and discussed.     

G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer

cis-[PtCl2(NH3)(2-picoline)] (AMD473) is a sterically-hindered anticancer complex with a profile of chemical and biological activity that differs significantly from that of cisplatin. Adducts of AMD473 with neutral 9-ethylguanine (9-EtGH) and anionic (N1-deprotonated) 9-ethylguanine (9-EtG) as perchlorate and nitrate salts, and also a nitrate salt of the trans isomer (AMD443), were prepared and their structures determined by X-ray crystallography: cis-[Pt(NH3)(2-pic)(9-EtGH)2](ClO4)2 (1).2H(2)OMe(2)CO, cis-[Pt(NH3)(2-pic)(9-EtGH)2](NO3)2 (2).2H2O, cis-[Pt(NH3)(2-pic)(9-EtGH)(9-EtG)]NO3 (3),3.5 H2O, trans-[Pt(NH3)(2-pic)(9-EtGH)(9-EtG)]NO3 (4).8H2O. In all cases, platinum coordination is through N7 of neutral (1, 2) and anionic (3, 4) guanine. In each complex, the guanine bases are arranged in the head-to-tail conformation. In complex 1, there is an infinite array of six-molecule cycles, based on both hydrogen bonding and pi-pi stacking of the 2-picoline and guanine rings. Platinum(II) coordinated at N7 acidifies the N1 proton of neutral 9-ethylguanine (pKa = 9.57) to give pKa1 = 8.40 and pKa2 = 8.75 for complex 2, and pKa1 = 7.77 and pKa2 = 9.00 for complex 4. In complexes 3 and 4, three intermolecular hydrogen bonds are formed between neutral and deprotonated guanine ligands involving O6, N1 and N2 sites. Unusually, both of the platinated guanine bases of complexes 3 and 4 participate in this triple G triple bond G hydrogen bonding. This is the first report of X-ray crystal structures of nucleobase adducts of the promising anticancer drug AMD473.     

One-dimensional phosphinite platinum chains based on hydrogen bonding interactions and phosphinite tetranuclear platinum(II)-thallium(I) complexes

The mononuclear pentafluorophenyl platinum complex containing the chelated diphenylphosphinous acid/diphenylphosphinite system [Pt(C(6)F(5)){(PPh(2)O)(2)H}(PPh(2)OH)] 1 has been prepared and characterised. 1 and the related alkynyl complex [Pt(C[triple bond, length as m-dash]CBu(t)){(PPh(2)O)(2)H}(PPh(2)OH)] 2 form infinite one-dimensional chains in the solid state based on intermolecular O-H[dot dot dot]O hydrogen bonding interactions. Deprotonation reactions of [PtL{(PPh(2)O)(2)H}(PPh(2)OH)] (L = C(6)F(5), C[triple bond, length as m-dash]CBu(t), C[triple bond, length as m-dash]CPh 3) with [Tl(acac)] yields tetranuclear Pt(2)Tl(2) complexes [PtL{(PPh(2)O)(2)H}(PPh(2)O)Tl](2) (L = C(6)F(5) 4, C[triple bond, length as m-dash]CBu(t), C[triple bond, length as m-dash]CPh ). The structure of the tert-butylalkynyl derivative , established by X-ray diffraction, shows two anionic discrete units [Pt(C[triple bond, length as m-dash]CBu(t)){(PPh(2)O)(2)H}(PPh(2)O)](-) joined by two Tl(i) centres via Tl-O and Pt-Tl bonds. Despite the existence of Pt-Tl interactions, they do not show luminescence.     

The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study

The mechanism of the formation of dinuclear platinum(II) mu-hydroxo complexes from cisplatin hydrolysis products, their interconversion, decomposition, and reactions with biomolecules has been explored using a combined DFT/CDM approach. All activation barriers for the formation of [cis-{Pt(NH(3))(2)(X)}-(mu-OH)-cis-{Pt(NH(3))(2)(Y)}](n)()(+) (X, Y = Cl, OH(2), OH) via nucleophilic attack of a hydroxo complex on an aqua complex are lower than the activation barriers for cisplatin hydrolysis. Considering therapeutic Pt(II) concentrations in tumors, however, only the reaction between two molecules of cis-[Pt(NH(3))(2)(OH(2))(OH)](+) (E) yielding [cis-{Pt(NH(3))(2)(OH(2))}-(mu-OH)-cis-{Pt(NH(3))(2)(OH)}](2+) (5) remains kinetically superior to cisplatin hydrolysis. 5 is strongly stabilized by intramolecular hydrogen bonding between the terminal aqua and hydroxo ligands, resulting in an unusually high pK(a) of 5 and a low pK(a) of its conjugate acid. Unimolecular cyclization of 5 yields the dimers [cis-{Pt(NH(3))(2)}(mu-OH)](2)(2+) (7a with antiperiplanar OH groups and 7b with synperiplanar OH groups). The electronic structure of several diplatinum(II) complexes has been analyzed to clarify whether there are metal-metal interactions. The overall reactivity to guanine (Gua) and dimethyl sulfide (Met, representing the thioether functional group of methionine) increases in the order 5 < 7a approximately 7b < mononuclear complexes, whereas the kinetic selectivity to Gua relative to Met increases in the order 7a approximately 5 < 7b approximately monocationic mononuclear complexes < dicationic mononuclear complex. The results of this work (i) help assess whether dinuclear metabolites play a role in cisplatin chemotherapy, (ii) elucidate the toxicity and pharmacological inactivity of [cis-{Pt(NH(3))(2)}(mu-OH)](2)(2+), and (iii) suggest future investigations of dinuclear anticancer complexes that contain one mu-hydroxo ligand.     

Synthesis and characterization of new five-coordinate platinum nitrosyl derivatives: density functional theory study of their electronic structure

The neutral, five-coordinate platinum nitrosyl compounds [Pt(C(6)F(5))(3)(L)(NO)] (2) [L=CNtBu (2 a), NC(5)H(4)Me-4 (2 b), PPhMe(2) (2 c), PPh(3) (2 d) and tht (2 e)] have been prepared by the reaction of [NBu(4)][Pt(C(6)F(5))(3)(L)] (1) with NOClO(4) in CH(2)Cl(2). The ionic compound [N(PPh(3))(2)][Pt(C(6)F(5))(4)(NO)] (4) has been prepared in a similar way starting from the homoleptic species [N(PPh(3))(2)](2)[Pt(C(6)F(5))(4)] (3). Compounds 2 and 4 are all diamagnetic with [PtNO](8) electronic configuration and show nu(NO) stretching frequencies at around 1800 cm(-1). The crystal and molecular structures of 2 c and 4 have been established by X-ray diffraction methods. The coordination environment for the Pt center in both compounds can be described as square pyramidal (SPY-5). Bent nitrosyl coordination is observed in both cases with Pt-N-O angles of 120.1(6) and 130.2(7) degrees for 2 c and 4, respectively. The bonding mechanism of the nitrosyl ligand coordinated to various model [Pt(II)R(4)](2-) (R=H, Me, Cl, CN, C(6)F(5) or C(6)Cl(5)) and [Pt(C(6)F(5))(3)(L)](-) (L=CNMe, PH(3)) systems has been studied by density functional calculations at the B3LYP level of theory, using the SDD basis set. The R(4)Pt-NO and (C(6)F(5))(3)(L)Pt-NO interactions generally involve two components: i) a direct Pt-NO bonding interaction and ii) multicenter-bonding interactions between the N atom of the NO ligand and the donor atoms of the R and L ligands. Moreover, with the more complex R groups, C(6)F(5) or C(6)Cl(5), a third component has been found to arise, which involves multicenter electrostatic interactions between the positively charged NO ligand and the negatively charged halo-substituents in the ortho-position of the C(6)X(5) groups (X=F, Cl). The contribution of each component to the Pt-NO bonding in R(4)Pt-NO and (C(6)F(5))(3)(L)Pt-NO compounds seems to be modulated by the electronic and steric effects of the R and L ligands.     

Combined effects of electrostatic and pi-pi stacking interactions: selective binding of nucleotides and aromatic carboxylates by platinum(II)-aromatic ligand complexes

Adduct formations of Pt(II) complexes containing an aromatic diimine (DA) and an L-amino acid (A) with an aromatic carboxylate (AR) or a mononucleotide (NMP) has been studied by synthetic, structural, spectroscopic, and calorimetric methods. Several adducts between Pt(II) complexes, [Pt(DA)(L-A)] (charges are omitted; DA=2,2'-bipyrimidine (bpm); A=L-arginine (L-Arg), L-alaninate (L-Ala), and AR (=indole-3-acetate (IA), gentisate (GA)) or GMP were isolated as crystals and structurally characterized by the X-ray diffraction method. GMP in [Pt(bpm)(Arg)](GMP).5 H(2)O was revealed to be bound through the pi-pi stacking and guanidinium-phosphate hydrogen bonds. The [Pt(DA)(A)]-AR and -NMP systems in aqueous solution exhibited NMR upfield shifts of the aromatic ring proton signals due to stacking. The stability constants (K) for the adducts were determined by absorption and NMR spectra and calorimetric titrations. The log K values were found to be in the range 1.40-2.29 for AR and 1.8-3.3 for NMP, the order for NMP being GMP>AMP>CMP>UMP. The DeltaH degrees values were negative for all the systems studied, and the values for AR (=IA and GA) were more negative than those for NMP, indicating that ARs are stronger electron donors than NMPs. Comparison of the log K values for [Pt(bpm)(L-Arg)] and [Pt(bpm)(L-Ala)] (Ala=alaninate) indicated that the Arg moiety further stabilized the adducts by the guanidinium-carboxylate or -phosphate hydrogen bonds. The combined effects of weak interactions on the stability of the adducts in solution are discussed on the basis of the thermodynamic parameters and solid state structures.     

Mono- and diprotonation of the superbasic bisguanidine 1,2-Bis(N,N,N',N'-tetramethylguanidino)benzene (btmgb) and Pt II and Pt IV complexes of chelating bisguanidines and guanidinates

New Pt complexes of chelating bisguanidines and guanidinate ligands were synthesized and characterized. 1,2-Bis(N,N,N',N'-tetramethylguanidino)benzene (btmgb) was used as a neutral chelating bisguanidine ligand, and 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidinate (hpp(-)) as a guanidinate ligand. The salts [btmgbH](+)[HOB(C(6)F(5))(3)](-) and [btmgbH(2)]Cl(2) and the complexes [(btmgb)PtCl(2)], [(btmgb)PtCl(dmso)](+)[PtCl(3)(dmso)](-), and [(btmgb)PtCl(dmso)](+)[Cl(-)] were synthesized and characterized. In the [btmgbH](+) cation the proton is bound to only one N atom. In the other complexes, both imine N atoms are coordinated to the Pt(II), thus adopting a eta(2)-coordinational mode. The hpp(-) anion, which usually prefers a bridging binding mode in dinuclear complexes, is eta(2)-coordinated in the Pt(IV) complex [(eta(2)-hpp)(hppH)PtCl(2){N(H)C(O)CH(3)}], which is formed (in low yield) by reaction between cis-[(hppH)(2)PtCl(2)] and H(2)O(2) in CH(3)CN.     

High-nuclearity Pt-Tl-Fe complexes: structural, electrochemistry, and spectroelectrochemistry studies

A series of heteropolynuclear Pt-Tl-Fe complexes have been synthesized and structurally characterized. The final structures strongly depend on the geometry of the precursor and the Pt/Tl ratio used. Thus, the anionic heteroleptic cis-configured [cis-Pt(C(6)F(5))(2)(C≡CFc)(2)](2-) and [Pt(bzq)(C≡CFc)(2)](-) (Fc = ferrocenyl) complexes react with Tl(+) to form discrete octanuclear (PPh(3)Me)(2)[{trans,cis,cis-PtTl(C(6)F(5))(2)(C≡CFc)(2)}(2)] (1), [PtTl(bzq)(C≡CFc)(2)](2) (5; bzq = benzoquinolate), and decanuclear [trans,cis,cis-PtTl(2)(C(6)F(5))(2)(C≡CFc)(2)](2) (3) derivatives, stabilized by both Pt(II)···Tl(I) and Tl(I)···η(2)(alkynyl) bonds. By contrast, Q(2)[trans-Pt(C(6)F(5))(2)(C≡CFc)(2)] (Q = NBu(4)) reacts with Tl(+) to give the one-dimensional (1-D) anionic [(NBu(4)){trans,trans,trans-PtTl(C(6)F(5))(2)(C≡CFc)(2)}](n) (2) and neutral [trans,trans,trans-PtTl(2)(C(6)F(5))(2)(C≡CFc)(2)](n) (4) polymeric chains based on [PtFc(2)](2-) platinate fragments and Tl(+) (2) or [Tl···Tl](2+) (4) units, respectively, connected by Pt(II)···Tl(I) and secondary weak κ-η(1) (2) or η(2) (4) alkynyl···Tl(I) bonding. The formation of 1-4 is reversible, and thus treatment of neutral 3 and 4 with PPh(3)MeBr causes the precipitation of TlBr, returning toward the formation of the anionic 1 and 2' (Q = PPh(3)Me). Two slightly different pseudopolymorphs were found for 2', depending on the crystallization solvent. Finally, the reaction of the homoleptic [Pt(C≡CFc)(4)](2-) with 2 equiv of Tl(+) affords the tetradecanuclear sandwich type complex [Pt(2)Tl(4)(C≡CFc)(8)] (6). Electrochemical, spectroelectrochemical, and theoretical studies have been carried out to elucidate the effect produced by the interaction of the Tl(+) with the Pt-C≡CFc fragments. The cyclic voltammetry (CV) and differential pulse voltammetry (DPV) of 1-5 reveal that, in general, neutralization of the anionic fragments increases the stability of the fully oxidized species and gives higher E(1/2) (Fc) values than those observed in their precursors, increasing with the number of Pt-Tl bonding interactions. However, the electronic communication between Fc groups is reduced or even lost upon Tl(+) coordination, as confirmed by electrochemical (CVs and DPVs voltammograms, 1-5) and spectroelectrochemical (UV-vis-NIR, 2-4) studies. Complexes 2 and 4 still display some electronic interaction between the Fc groups, supported by the presence of an IVCT band in their UV-vis-NIR spectra of oxidized species and additional comparative DFT calculations with the precursor [trans-Pt(C(6)F(5))(2)(C≡CFc)(2)](2-) and complex 3.     

Polymeric silver(I) complexes with pyridyl dithioether ligands: experimental and theoretical investigations on the coordination properties of the ligands

The reactions of four flexible tetradentate ligands, 1,3-bis(2-pyridylthio)propane (L1), 1,4-bis(2-pyridylthio)butane (L2), 1,5-bis(2-pyridylthio)pentane (L3) and 1,6-bis(2-pyridylthio)hexane (L4) with AgX (X = BF4-, ClO4-, PF6-, or CF3SO3-) lead to the formation of seven new complexes: [AgL1(BF4)]2 (1), [[AgL2](ClO4)]infinity (2), [[AgL2(CH3CN)](PF6)]infinity (3), [[AgL3](BF4)(CHCl3)]2 (4), [[AgL3(CF3SO3)](CH3OH)(0.5)]infinity (5), [[Ag2L4(2)](BF4)2]infinity (6), and [[AgL4](PF6)]infinity (7), which have been characterized by elemental analyses, IR spectroscopy, and X-ray crystallography. Single-crystal X-ray analyses show that complexes 1 and 4 possess dinuclear macrometallacyclic structures, and complexes 2, 3 and 5-7 take chain structures. In all the complexes, the nitrogen atoms of ligands preferentially coordinate to silver atoms to form normal coordination bonds, while the sulfur atoms only show weak interactions with silver atoms and the intermolecular AgS weak contacts connect the low-dimensional complexes into high-dimensional supramolecular networks. Additional weak interactions, such as pi-pi stacking, F...F weak interactions, Ag...O contacts or C-H...O hydrogen bonds, also help to stabilize the crystal structures. It was found that the parity of the -(CH2)n- spacers (n = 3-6) affect the orientation of the two terminal pyridyl rings, thereby significantly influence the framework formations of these complexes. The coordination features of ligands and their conformation changes between free and coordination states have been investigated by DFT calculations.     

Syntheses and Structures of the Complexes cis-[M(C(6)F(5))(2)(N&arcraise;X)] (M = Pd, Pt; N&arcraise;X = 2-Iodoaniline, 2-Benzoylpyridine) Containing N&arcraise;X Acting as a Didentate Chelating Ligand and Displaying I-->M or O-->M Interactions

Complexes cis-[M(C(6)F(5))(2)(THF)(2)] (M = Pd, Pt) are weak Lewis acids and react with the halocarbon ligand 2-iodoaniline (R-I) yielding the corresponding cis-[M(C(6)F(5))(2)(R-I)] [M = Pd (1), Pt (2)]. In these complexes a (C-)I-M bond is present. The use of other 2-haloanilines (halogen = F, Cl, Br) does not yield the analogous complexes because of the lesser nucleophilic character of the halogen involved. The presence of the (C-)I-Pt bond in 2 has been confirmed by an X-ray structure determination, which also reveals an N-H.M hydrogen bond between two neutral molecules. Complex 2 crystallizes in the space group P&onemacr;: Z = 4; a = 11.797(4) ?; b = 13.735(4) ?; c = 14.107(4) ?; alpha = 97.24(2) degrees; beta = 90.91(2) degrees; gamma = 99.44(2) degrees; V = 2235(2) ?(3). Similarly, complexes cis-[M(C(6)X(5))(2)(THF)(2)] (M = Pd, Pt; X = F, Cl) react with the ligand 2-benzoylpyridine {R-C(O)Ph}, in which the oxygen atom of the ketonic group can behave as a nucleophilic center, yielding the complexes cis-[M(C(6)X(5))(2){R-C(O)Ph}] [M = Pd, X = F (3); M = Pt, X = F (4), Cl (5)]. Complex 3 crystallizes in the space group C2/c: Z = 16; a = 26.284(3) ?; b = 10.623(1) ?; c = 31.423(4) ?; beta = 93.15(1) degrees; V = 8760(2) ?(3). The I-M or O-M bonds in complexes 1-5 are weak and can be easily broken by the addition of neutral (CO, PPh(3), and CH(3)CN) or anionic (Br(-)) ligands.     

Novel supramolecular architectures in group 13 perfluoroaryl complexes. Synthesis and structures of [AlMe(C6F5)(mu-Me)]2 and GaMe(C6F5)2

Novel supramolecular architectures are observed in the solid state structures of [AlMe(C6F5)(mu-Me)]2 (1) and Ga(C6F5)2Me (2) via pi-pi stacking between C6F5 rings and intermolecular aryl-F-->Ga interactions, respectively.     

Si-H and Si-Si activation at Pt: synthesis and reactivity of neutral and cationic silyl complexes

Reactions of [Pt(PEt(3))(3)] (1) with the silanes HSiPh(3), HSiPh(2)Me and HSi(OEt)(3) led to the products of oxidative addition, cis-[Pt(H)(SiPh(3))(PEt(3))(2)] (2), cis-[Pt(H)(SiPh(2)Me)(PEt(3))(2)] (3), cis-[Pt(H){Si(OEt)(3)}(PEt(3))(2)] (cis-4) and trans-[Pt(H){Si(OEt)(3)}(PEt(3))(2)] (trans-4). The complexes cis-4 and trans-4 can also be generated by hydrogenolysis of (EtO)(3)SiSi(OEt)(3) in the presence of 1. Furthermore, the silyl compounds cis-4 and trans-4 react with B(C(6)F(5))(3) and CH(3)CN by hydride abstraction to give the cationic silyl complex trans-[Pt{Si(OEt)(3)}(NCCH(3))(PEt(3))(2)][HB(C(6)F(5))(3)] (8). In addition, the reactivity of the complexes cis-4, trans-4 and 8 towards alkenes and CO was studied using NMR experiments.     

Synthesis and characterization of mono- and binuclear platinum complexes containing terminal and bridging diynyldiphenylphosphine ligands

A series of mononuclear platinum complexes containing diynyldiphenylphosphine ligands [cis-Pt(C(6)F(5))(2)(PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CR)L](n)(n= 0, L = tht, R = Ph 2a, Bu(t)2b; L = PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CR, 4a, 4b; n=-1, L = CN(-), 3a, 3b) has been synthesized and the X-ray crystal structures of 4a and 4b have been determined. In order to compare the eta2-bonding capability of the inner and outer alkyne units, the reactivity of towards [cis-Pt(C(6)F(5))(2)(thf)(2)] or [Pt(eta2)-C(2)H(4))(PPh(3))(2)] has been examined. Complexes coordinate the fragment "cis-Pt(C(6)F(5))(2)" using the inner alkynyl fragment and the sulfur of the tht ligand giving rise the binuclear derivatives [(C(6)F(5))(2)Pt(mu-tht)(mu-1kappaP:2eta2-C(alpha),C(beta)-PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CR)Pt(C(6)F(5))(2)](R = Ph 5a, Bu(t)5b). The phenyldiynylphosphine complexes 2a, 3a and 4a react with [Pt(eta2)-C(2)H(4))(PPh(3))(2)] to give the mixed-valence Pt(II)-Pt(0) complexes [((C(6)F(5))(2)LPt(mu-1kappaP:2eta2)-C(5),C(6)-PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CPh))Pt(PPh(3))(2)](n)(L = tht 6a, CN 8a and PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CPh 9a) in which the Pt(0) fragment is eta2-complexed by the outer fragment. Complex 6a isomerizes in solution to a final complex [((C(6)F(5))(2)(tht)Pt(mu-1kappaP:2eta2)-C(alpha),C(beta)-PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CPh))Pt(PPh(3))(2)]7a having the Pt(0) fragment coordinated to the inner alkyne function. In contrast, the tert-butyldiynylphosphine complexes 2b and 3b coordinate the Pt(0) unit through the phosphorus substituted inner acetylenic entity yielding 7b and 8b. By using 4a and 2 equiv. of [Pt(eta2)-C(2)H(4))(PPh(3))(2)] as precursors, the synthesis of the trinuclear complex [cis-((C(6)F(5))(2)Pt(mu-1kappaP:2eta2)-C(5),C(6)-PPh(2)C[triple bond]CC(6)H(4)C[triple bond]CPh)(2))(Pt(PPh(3))(2))(2)]10a, bearing two Pt(0)(PPh(3))(2)eta2)-coordinated to the outer alkyne functions is achieved. The structure of 7a has been confirmed by single-crystal X-ray diffraction.